Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose

NCT02864472 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Age-related Macular Degeneration

Interventions

PROCEDURE: PDT
DRUG: Ranibizumab
DRUG: ranibizumab PRN

Sponsor

Seoul National University Hospital

Collaborators

[object Object]